Form 4 for SNPS Synopsys
Accepted 2022-05-27 00:00:00 ET · period of report 2022-05-25 · accession 0001199719-22-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-27 | 2022-05-25+ | SNPS | Pham Trac | CFO | S - Sale+OE | $303.10 | -74.1K | 58.2K | -56% | -$22.45M |
| DM | 2022-05-27 | 2022-05-25+ | SNPS | Pham Trac | CFO | M - OptEx | $113.93 | +74.1K | 82.8K | +844% | +$8.44M |
| DM | 2022-05-27 | 2022-05-25+ | SNPS | Pham Trac | CFO | M - OptEx | $0.00 | -74.1K | 19.2K | -79% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-26 | S | D | 4,529 | $305.00 | 58,204 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-26 | M | A | 4,529 | $234.17 | 62,733 | D | — | — | |
| 3 | Common | Common Stock | 2022-05-25 | M | A | 25,000 | $89.76 | 83,204 | D | — | — | |
| 4 | Common | Common Stock | 2022-05-25 | S | D | 25,000 | $299.36 | 58,204 | D | — | — | (F1) Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $298.34 to $301.56. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. |
| 5 | Common | Common Stock | 2022-05-26 | S | D | 24,643 | $305.00 | 58,204 | D | — | — | |
| 6 | Common | Common Stock | 2022-05-26 | M | A | 19,900 | $89.76 | 78,104 | D | — | — | |
| 7 | Common | Common Stock | 2022-05-26 | S | D | 19,900 | $305.00 | 58,204 | D | — | — | |
| 8 | Common | Common Stock | 2022-05-26 | M | A | 24,643 | $135.88 | 82,847 | D | — | — | |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-05-26 | M | D | 4,529 | $0.00 | 9,965 | D | $234.17 · 2021-12-10 to 2027-12-10 | 4,529 Common Stock | (F2) 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-05-25 | M | D | 25,000 | $0.00 | 30,262 | D | $89.76 · 2019-12-12 to 2025-12-12 | 25,000 Common Stock | (F2) 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-05-26 | M | D | 19,900 | $0.00 | 10,362 | D | $89.76 · 2019-12-12 to 2025-12-12 | 19,900 Common Stock | (F2) 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-05-26 | M | D | 24,643 | $0.00 | 19,168 | D | $135.88 · 2020-12-12 to 2026-12-12 | 24,643 Common Stock | (F2) 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |